10x Genomics v Curio Bioscience (CFI, 8 August 2024)
| Date | 8 August 2024 |
|---|---|
| Court | CFI |
| Division | Düsseldorf (DE) Local Division |
| Type of action | Application RoP262A |
| Registry reference | App_41690/2024 · ORD_42284/2024 |
| Parties | Curio Bioscience, Inc v. 10x Genomics, Inc. |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By order of 8 August 2024 (UPC_CFI_140/2024, ACT_15774/2024, App_41690/2024), the judge-rapporteur of the Düsseldorf Local Division classified as confidential under Rule 262A RoP Curio Bioscience’s unredacted Statement of Defence, its updated version and two exhibits, in 10x Genomics’ infringement action on EP 2 697 391. Access is granted to two named representatives of 10x Genomics, their teams and named employees. The order clarifies how it relates to the orders made in the earlier provisional measures proceedings (UPC_CFI_463/2023).
Question
Do confidentiality orders made in summary proceedings carry over automatically to the main action, and on what basis can the access circle be widened there?
Decision
Orders made in summary proceedings do not preclude a new order in the main action, and the parties may seek different terms there, as the main action calls for a different balance between the right to be heard, speed and confidentiality (paragraph 3). As confidentiality was not seriously disputed, the information is protected (paragraph 4). There is normally no reason to cap the number of representatives or to confine access to UPC representatives, but Rule 262A.6 RoP requires access to be no wider than necessary and accountability to be clear: the named representatives answer for their teams (paragraph 5). Once a party has named its persons, the other party must justify any objection, which Curio did not do for the three employees (paragraph 6).
Key points for practice
- Practical point: a confidentiality order made in summary proceedings does not automatically carry over to the main action, a fresh application is needed and may redefine the access circle.
Provisions applied
- Agreement on a Unified Patent Court
- Art. 58
- Rules of Procedure
- Rule 262A
- Other provisions
- Directive (EU) 2016/943, Art. 9
- Case law cited
- Avago v Tesla Germany, Hamburg Local Division, 3 November 2023, 10x Genomics v Curio Bioscience, Düsseldorf Local Division, 23 February 2024, UPC_CFI_463/2023, 10x Genomics v Curio Bioscience, Düsseldorf Local Division, 11 March 2024, 10x Genomics v Curio Bioscience, Düsseldorf Local Division, 22 March 2024, Aylo Freesites v DISH, Mannheim Local Division, 3 July 2024
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Confidentiality club.
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- defendant10x Genomics, Inc.57 decisions in the corpusFollow this party
- claimantCurio Bioscience, Inc.29 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Application RoP262A
- Outcome (Dhenne Avocats summary)
- Le mémoire en défense et deux pièces de Curio sont classés confidentiels. L'accès est ouvert à deux représentants nommés de 10x Genomics, à leurs équipes et à des salariés désignés, une nouvelle ordonnance étant possible au fond.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 2 697 391mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- AYLO FREESITES v DISH (CFI, 3 July 2024) cited in this record
- 10x Genomics v Curio Bioscience (CFI, 22 March 2024) cited in this record
- 10x Genomics v Curio Bioscience (CFI, 11 March 2024) cited in this record
- Avago Technologies International Sales v Tesla Germany (CFI, 3 November 2023) cited in this record
- QIAGEN Sciences v bioMérieux (CFI, 15 July 2025) cites this decision
- Ona Patents v Apple (CFI, 30 August 2024) cites this decision
- Valeo Electrification v Magna PT (CFI, 21 August 2024) cites this decision
- NEC v TCL Deutschland (CFI, ORD_41184/2024, 14 August 2024) cites this decision
- NEC v TCL Deutschland (CFI, ORD_41183/2024, 14 August 2024) cites this decision
- Abbott Diabetes Care v Dexcom (CFI, 9 August 2024) cites this decision
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 2 697 391Method and product for localised or spatial detection of nucleic acid in a tissue sample recorded proprietor: Spatial Transcriptomics AB | Mentioned in the analysis (role not qualified) Also mentioned in 28 other decision(s): 10x Genomics v Curio Bioscience (CFI, ORD_598272/2023, 30 April 2024) · 10x Genomics v Curio Bioscience (CFI, UPC_CFI_658/2025, 2 February 202 · 10x Genomics v Curio Bioscience (CFI, UPC_CFI_657/2025, 2 February 202 · 10x Genomics v Curio Bioscience (CFI, 5 August 2025) · 10x Genomics v Curio Bioscience (CFI, 4 August 2025) · 10x Genomics v Curio Bioscience (CFI, 16 June 2025) · 10x Genomics v Curio Bioscience (CFI, 4 June 2025) · 10x Genomics v Curio Bioscience (CFI, 2 May 2025) | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.